Quest Diagnostics DGX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 33.2%+0.4pp | 33.2%+0.4pp | 33.3%+0.6pp | 33%+0.2pp | 32.8%0.0pp | |
| Operating margin | 14.3%+0.6pp | 14.1%+0.5pp | 14.1%+1.0pp | 14%+0.5pp | 13.7%+0.2pp | |
| Net margin | 9.1%+0.2pp | 9%+0.2pp | 8.9%+0.1pp | 9%0.0pp | 8.8%-0.3pp | |
| EBITDA margin | 19.4%+0.6pp | 19.3%+0.6pp | 19.3%+1.3pp | 19.2%+0.8pp | 18.8%+0.4pp | |
| Free cash flow margin | 11.8%+1.4pp | 12.3%+3.1pp | 12.8%+2.1pp | 11.6%+2.3pp | 10.4%+0.2pp | |
| Returns | ||||||
| Return on equity | 14.3%+0.9pp | 14.2%+0.9pp | 13.8%+1.1pp | 13.7%+0.7pp | 13.4%-0.1pp | |
| Return on assets | 6.3%+0.3pp | 6.1%+0.4pp | 6%+0.3pp | 6.4%+0.2pp | 6%-0.3pp | |
| Return on invested capital | 9.2%+0.4pp | 9%+0.5pp | 8.9%+0.9pp | 9.2%+0.5pp | 8.8%-0.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | |
| Inventory turnover | 36.4×-0.5× | 39.1×+4.0× | 39.1×+4.2× | 38.2×+3.9× | 36.9×+3.3× | |
| Liquidity | ||||||
| Current ratio | 1.2×-0.3× | 1×-0.1× | 1.1×-0.1× | 1.1×+0.1× | 1.4×+0.5× | |
| Quick ratio | 1.1×-0.2× | 1×-0.1× | 1×-0.1× | 1×+0.1× | 1.3×+0.4× | |
| Cash ratio | 0.2×0.0× | 0.2×-0.1× | 0.2×-0.2× | 0.2×0.0× | 0.1×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.9×-0.1× | 0.9×-0.1× | 0.9×-0.1× | 0.9×+0.1× | 0.9×+0.1× | |
| Debt-to-assets | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Net debt / EBITDA | 2.8×-0.6× | 2.8×-0.7× | 2.8×-0.8× | 3×+0.2× | 3.3×+0.5× | |
| Per Share | ||||||
| Book value per share | $65.77+7.3% | —— | $64.23+6.6% | $63.96+8.3% | $61.32+6.8% | |
| Valuation | ||||||
| Market capitalization | $21.53B+14.7% | $19.3B+14.6% | $21.31B+23.3% | $20.08B+32.1% | $18.78B+27.4% | |
| Enterprise value | $27.54B+9.5% | $25.29B+8.8% | $27.26B+16.1% | $26.15B+30.6% | $25.16B+28.3% | |
| Price / earnings | 21×+0.1× | 19.5×+0.1× | 22×+1.4× | 21.1×+3.0× | 20.9×+3.5× | |
| Price / sales | 1.9×+0.1× | 1.7×0.0× | 2×+0.2× | 1.9×+0.3× | 1.8×+0.3× | |
| Price / book | 2.9×+0.2× | 2.7×+0.2× | 2.9×+0.4× | 2.8×+0.5× | 2.7×+0.4× | |
| EV / EBITDA | 12.6×-0.6× | 11.9×-0.7× | 13×-0.6× | 13×+1.3× | 13.2×+1.7× | |
| EV / sales | 2.4×0.0× | 2.3×-0.1× | 2.5×+0.1× | 2.5×+0.3× | 2.5×+0.4× | |
| Free cash flow yield | 6.2%+0.5pp | 7%+1.6pp | 6.5%+0.6pp | 6.1%+0.3pp | 5.6%-0.8pp | |
| Earnings yield | 4.8%0.0pp | 5.1%0.0pp | 4.5%-0.3pp | 4.7%-0.8pp | 4.8%-1.0pp | |
| Dividend yield | 1.7%-0.1pp | 1.8%-0.1pp | 1.6%-0.3pp | 1.7%-0.4pp | 1.8%-0.4pp | |
| PEG ratio | 1.5×-2.0× | 1.4×-8.3× | 1.4×-0.6× | 1.6×-1.5× | 3.5×+0.9× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Quest Diagnostics's profit margins?
- Quest Diagnostics (DGX) runs a 33.2% gross margin and a 14.3% operating margin, with a 9.1% net margin.
- Where do Quest Diagnostics's ratios come from?
- Every ratio is computed from Quest Diagnostics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
